Individuals diagnosed with Type 2 diabetes or pre-diabetes may be eligible for AI-powered metabolic reversal programs through participating employer health plans or clinical providers.
Mandatory Requirements
Clinical diagnosis of Type 2 diabetes, pre-diabetes, or metabolic syndrome.
Requirement to use continuous glucose monitors (CGM) and other wearable health sensors.
Enrollment through a supporting employer-sponsored health plan or partner healthcare provider.
Patients must have a diagnosis of Type 2 diabetes, prediabetes, or a related metabolic condition.
Participants must be willing to use wearable devices such as continuous glucose monitors and smart scales.
Access is generally provided through participating employer health plans or specific health insurance providers.
Policy & Intake Updates
Twin Health has closed a $50 million funding round to expand the reach of its 'Whole Body Digital Twin' technology, which helps patients manage and reverse chronic metabolic conditions through data-driven personalized care.
View Source Verification →